Hinge Health (NYSE:HNGE) President James Pursley Sells 33,000 Shares

Hinge Health Inc. (NYSE:HNGEGet Free Report) President James Pursley sold 33,000 shares of the business’s stock in a transaction dated Monday, September 21st. The shares were sold at an average price of $94.14, for a total value of $3,106,620.00. Following the completion of the transaction, the president directly owned 666,909 shares of the company’s stock, valued at approximately $62,782,813.26. This trade represents a 4.71% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

James Pursley also recently made the following trade(s):

  • On Friday, August 21st, James Pursley sold 33,000 shares of Hinge Health stock. The stock was sold at an average price of $88.05, for a total value of $2,905,650.00.

Hinge Health Stock Performance

NYSE HNGE traded down $1.88 during mid-day trading on Wednesday, reaching $92.27. 1,702,459 shares of the stock were exchanged, compared to its average volume of 1,586,792. The business’s 50 day moving average is $86.84 and its 200-day moving average is $66.66. The company has a market capitalization of $7.45 billion, a P/E ratio of 72.09 and a beta of 1.38. Hinge Health Inc. has a 1 year low of $30.08 and a 1 year high of $96.66.

Hinge Health (NYSE:HNGEGet Free Report) last posted its earnings results on Tuesday, August 4th. The company reported $0.59 EPS for the quarter, beating analysts’ consensus estimates of $0.28 by $0.31. The firm had revenue of $212.82 million for the quarter. Hinge Health had a return on equity of 51.60% and a net margin of 15.15%.Hinge Health’s revenue was up 53.0% on a year-over-year basis. During the same quarter last year, the business earned $0.59 earnings per share. Equities analysts predict that Hinge Health Inc. will post 1.25 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on HNGE. Robert W. Baird upped their price target on shares of Hinge Health from $85.00 to $90.00 and gave the stock a “neutral” rating in a research report on Tuesday. Canaccord Genuity Group set a $105.00 price objective on Hinge Health in a report on Wednesday, August 5th. Citigroup reissued an “outperform” rating on shares of Hinge Health in a report on Monday, July 27th. Needham & Company LLC raised their target price on Hinge Health from $76.00 to $97.00 and gave the company a “buy” rating in a research report on Wednesday, August 5th. Finally, Wells Fargo & Company lifted their price target on Hinge Health from $90.00 to $103.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 5th. One analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $103.71.

Check Out Our Latest Report on Hinge Health

Institutional Trading of Hinge Health

Several large investors have recently bought and sold shares of HNGE. Caitong International Asset Management Co. Ltd acquired a new stake in Hinge Health in the 4th quarter valued at about $26,000. IFP Advisors Inc boosted its holdings in shares of Hinge Health by 140.0% during the 2nd quarter. IFP Advisors Inc now owns 324 shares of the company’s stock worth $27,000 after purchasing an additional 189 shares during the last quarter. Nykredit A S purchased a new stake in shares of Hinge Health in the second quarter valued at approximately $29,000. CENTRAL TRUST Co acquired a new stake in shares of Hinge Health in the first quarter valued at approximately $37,000. Finally, State of Wyoming acquired a new stake in shares of Hinge Health in the first quarter valued at approximately $110,000.

About Hinge Health

(Get Free Report)

Hinge Health, Inc is a digital health company focused on musculoskeletal care. The company provides virtual programs designed to help people manage and improve conditions affecting the back, joints and other areas of the musculoskeletal system, with the goal of supporting conservative care and reducing the need for more invasive treatment.

Its platform combines personalized exercise therapy, digital tools, clinical guidance and behavioral support. Depending on the program, members may use the Hinge Health mobile application, wearable motion sensors and remote care from physical therapists, health coaches and other clinicians.

See Also

Insider Buying and Selling by Quarter for Hinge Health (NYSE:HNGE)

Receive News & Ratings for Hinge Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hinge Health and related companies with MarketBeat.com's FREE daily email newsletter.